Rasmussen College | NUR 2407 / NUR 2474 Pharmacology Exam 2
NUR 2407 / NUR 2474 Pharmacology Exam 2
Comprehensive Examination 2026/2027 |
Verified Questions
Rasmussen College | NUR 2407 / NUR 2474 Pharmacology Exam 2 | University-Level Nursing Students
50 Verified Questions | 4 Core Domains | Academic Year 2026/2027
Prepared by
Rasmussen College | NUR 2407 / NUR 2474 Pharmacology Exam 2
Examination 2 Actual Exam | Academic Year 2026/2027
NUR 2407 / NUR 2474 Pharmacology Exam 2 Comprehensive Examination 2026/2027 | Verified Questions
, INTRODUCTION
This Examination 2 Comprehensive Examination contains 50 verified questions designed for university-
level nursing students enrolled in NUR 2407 / NUR 2474 Pharmacology at Rasmussen College. The
questions are distributed across four core domains: Endocrine and Diabetes Pharmacology (13 questions),
Gastrointestinal Pharmacology (13 questions), Respiratory Pharmacology (12 questions), and
Cardiovascular Pharmacology (12 questions). All content is original and constructed to reinforce the
official NUR 2407 / NUR 2474 Examination 2 course objectives for actual exam readiness and clinical
proficiency, aligned to the 2026/2027 academic year. Each item emphasizes drug mechanisms, safe
administration, monitoring parameters, and essential client teaching drawn from foundational
pharmacology methodology.
ACTUAL QUESTIONS
Domain 1: Endocrine and Diabetes Pharmacology
Question 1. Which insulin formulation has an onset of action of approximately 15 minutes
and is typically administered immediately before meals?
A. Insulin lispro (rapid-acting analog)
B. Insulin glargine
C. Insulin detemir
D. Neutral protamine Hagedorn (NPH) insulin
Correct Answer: A
Rationale: Rapid-acting insulin analogs such as lispro, aspart, and glulisine have an onset of about 10–
20 minutes, peak within 1–2 hours, and are intended for prandial coverage. Long-acting basal insulins
(glargine, detemir) and intermediate-acting NPH have slower onsets and are not used for mealtime
coverage.
Question 2. A client with type 2 diabetes is prescribed metformin. Which laboratory value
should be assessed before initiation and periodically thereafter because of the risk of lactic
acidosis?
A. Serum potassium
B. Serum calcium
C. Serum creatinine or estimated glomerular filtration rate
D. Thyroid-stimulating hormone
Correct Answer: C
Rationale: Metformin is contraindicated in significant renal impairment because reduced clearance
increases the risk of lactic acidosis. Baseline and periodic assessment of renal function (creatinine or
eGFR) is required before and during therapy.
Question 3. Which adverse effect is most characteristic of sulfonylurea therapy and
requires client teaching about recognition and management?
A. Hyperglycemia during illness
B. Hypoglycemia, especially if meals are delayed or activity is increased
C. Severe hypokalemia
D. Ototoxicity
Correct Answer: B
Rationale: Sulfonylureas stimulate insulin release from pancreatic beta cells regardless of glucose level
and therefore carry a significant risk of hypoglycemia. Clients must be taught signs of low blood glucose
and appropriate treatment.
NUR 2407 / NUR 2474 Pharmacology Exam 2 Comprehensive Examination 2026/2027 | Verified Questions
NUR 2407 / NUR 2474 Pharmacology Exam 2
Comprehensive Examination 2026/2027 |
Verified Questions
Rasmussen College | NUR 2407 / NUR 2474 Pharmacology Exam 2 | University-Level Nursing Students
50 Verified Questions | 4 Core Domains | Academic Year 2026/2027
Prepared by
Rasmussen College | NUR 2407 / NUR 2474 Pharmacology Exam 2
Examination 2 Actual Exam | Academic Year 2026/2027
NUR 2407 / NUR 2474 Pharmacology Exam 2 Comprehensive Examination 2026/2027 | Verified Questions
, INTRODUCTION
This Examination 2 Comprehensive Examination contains 50 verified questions designed for university-
level nursing students enrolled in NUR 2407 / NUR 2474 Pharmacology at Rasmussen College. The
questions are distributed across four core domains: Endocrine and Diabetes Pharmacology (13 questions),
Gastrointestinal Pharmacology (13 questions), Respiratory Pharmacology (12 questions), and
Cardiovascular Pharmacology (12 questions). All content is original and constructed to reinforce the
official NUR 2407 / NUR 2474 Examination 2 course objectives for actual exam readiness and clinical
proficiency, aligned to the 2026/2027 academic year. Each item emphasizes drug mechanisms, safe
administration, monitoring parameters, and essential client teaching drawn from foundational
pharmacology methodology.
ACTUAL QUESTIONS
Domain 1: Endocrine and Diabetes Pharmacology
Question 1. Which insulin formulation has an onset of action of approximately 15 minutes
and is typically administered immediately before meals?
A. Insulin lispro (rapid-acting analog)
B. Insulin glargine
C. Insulin detemir
D. Neutral protamine Hagedorn (NPH) insulin
Correct Answer: A
Rationale: Rapid-acting insulin analogs such as lispro, aspart, and glulisine have an onset of about 10–
20 minutes, peak within 1–2 hours, and are intended for prandial coverage. Long-acting basal insulins
(glargine, detemir) and intermediate-acting NPH have slower onsets and are not used for mealtime
coverage.
Question 2. A client with type 2 diabetes is prescribed metformin. Which laboratory value
should be assessed before initiation and periodically thereafter because of the risk of lactic
acidosis?
A. Serum potassium
B. Serum calcium
C. Serum creatinine or estimated glomerular filtration rate
D. Thyroid-stimulating hormone
Correct Answer: C
Rationale: Metformin is contraindicated in significant renal impairment because reduced clearance
increases the risk of lactic acidosis. Baseline and periodic assessment of renal function (creatinine or
eGFR) is required before and during therapy.
Question 3. Which adverse effect is most characteristic of sulfonylurea therapy and
requires client teaching about recognition and management?
A. Hyperglycemia during illness
B. Hypoglycemia, especially if meals are delayed or activity is increased
C. Severe hypokalemia
D. Ototoxicity
Correct Answer: B
Rationale: Sulfonylureas stimulate insulin release from pancreatic beta cells regardless of glucose level
and therefore carry a significant risk of hypoglycemia. Clients must be taught signs of low blood glucose
and appropriate treatment.
NUR 2407 / NUR 2474 Pharmacology Exam 2 Comprehensive Examination 2026/2027 | Verified Questions
